On the sidelines of the visit of Saudi Arabia’s Crown Prince to London, Saudi institutions and businesses signed agreements worth more than $2.13 bln (SAR 8.9 bln) with British bodies and companies.
Agreements signed included the sectors of health, investment, innovation and energy.
Among the deals signed during the trip is the investment of one billion Saudi riyals on health care centers in Saudi Arabia.
In a related context, the General Authority for Investment in Saudi Arabia granted 10 licenses for direct investment of UK companies in the Kingdom.
British pharmaceutical company AstraZeneca obtained a license to invest in Saudi Arabia.